SCHEMBL7546922

SCHEMBL7546922

COC(=O)c1cc(OC)ccc1-n1nc(C(F)(F)F)cc1C

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.48
PTGS2 P35354 8/20 0.43
PTGS1 P23219 4/20 0.43
TUBB4A P04350 1/20 0.43
TUBB P07437 1/20 0.43
TUBA3C P0DPH7 1/20 0.43
TUBA1B P68363 1/20 0.43
TUBA4A P68366 1/20 0.43
TUBB4B P68371 1/20 0.43
TUBB3 Q13509 1/20 0.43
TUBB2A Q13885 1/20 0.43
TUBB8 Q3ZCM7 1/20 0.43
TUBA3E Q6PEY2 1/20 0.43
TUBA1A Q71U36 1/20 0.43
TUBA1C Q9BQE3 1/20 0.43
TUBB6 Q9BUF5 1/20 0.43
TUBB2B Q9BVA1 1/20 0.43
TUBB1 Q9H4B7 1/20 0.43
CYP1A2 P05177 2/20 0.42
CYP2C9 P11712 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5097191 0.86 KLKB1 (0.45) MAPTPTGS2PTGS1TUBB4ATUBB
SCHEMBL12632739 0.84 MYC (0.52) MAPTKDM4EALDH1A1POLBTHRB
SCHEMBL2852699 0.84 LMNA (0.48) MAPTCYP1A2CYP2C9CYP2C19KDM4E
SCHEMBL5107199 0.82 KDM4E (0.45) MAPTPTGS2PTGS1KDM4EALDH1A1
SCHEMBL22143066 0.79 MAPT (0.44) MAPTKDM4EALDH1A1POLBTHRB
SCHEMBL31255120 0.77 CYP1A2 (0.50) PTGS2CYP1A2CYP2C9CYP2C19KDM4E
SCHEMBL31255121 0.77 CYP1A2 (0.50) PTGS2CYP1A2CYP2C9CYP2C19KDM4E
SCHEMBL5096940 0.74 KLKB1 (0.47) PTGS2PTGS1PTGER1
SCHEMBL7326434 0.74 TP53 (0.43) MAPTPTGS2KDM4EALDH1A1GAA
SCHEMBL6172133 0.74 PTGS2 (0.69) MAPTPTGS2PTGS1CYP1A2CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0991625-A2 INHIBITORS OF FACTOR XA WITH A NEUTRAL P1 SPECIFICITY GROUP THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 2000-04-12 EP disclosed
WO-1998057937-A2 INHIBITORS OF FACTOR XA WITH A NEUTRAL P1 SPECIFICITY GROUP THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1998-12-23 WO disclosed